Proton Pump Inhibitors and Hypomagnesemia in the General Population: A Population- Based Cohort Study  Brenda C.T. Kieboom, MD, Jessica C. Kiefte–de Jong, RD, PhD, Mark Eijgelsheim, MD, PhD, Oscar H. Franco, MD, PhD, Ernst J. Kuipers, MD, PhD, Albert Hofman, MD, PhD, Robert Zietse, MD, PhD, Bruno H. Stricker, MMed, PhD, Ewout J. Hoorn, MD, PhD  American Journal of Kidney Diseases  Volume 66, Issue 5, Pages 775-782 (November 2015) DOI: 10.1053/j.ajkd.2015.05.012 Copyright © 2015 National Kidney Foundation, Inc. Terms and Conditions

Figure 1 Distribution of serum magnesium levels among participants not using acid-suppressive medication, and participants who used proton pump inhibitors (PPIs) or H2 receptor antagonists (H2RAs). PPI users and H2RA users more often had a serum magnesium level in the lowest quartile. American Journal of Kidney Diseases 2015 66, 775-782DOI: (10.1053/j.ajkd.2015.05.012) Copyright © 2015 National Kidney Foundation, Inc. Terms and Conditions